Gold prices have risen by 7% in the last couple of days and the rally may continue given the yellow metal’s status as a safe haven during uncertain times.
In last few years, the stock has enjoyed good investor interest due to company's tie-up with 'Being Human', which although smaller in size was most profitable.
It has been observed that investing in companies with improving financials and low price-earnings (P/E) ratios give good returns over medium to long term.
Indian stocks are among the most favoured in emerging markets, but actual earnings performance may belie that sunny outlook.
The 8-10 pc rise till date has dented the company's financials in the recent quarter, resulting into the stock correcting by 20 pc in the current year.
In the healthcare segment, Vicks is the leader however, there are several other players in this category which will restrict its growth to 12-13 per cent.
Companies that catered to the domestic economy bettered market expectations for Q4 in contrast to export-dependent constituents.
Results declared by most Nifty companies have been either much better or worse than expected, resulting in their stock prices making sharp moves on results day.
FY17 is expected to be supportive of its performance as most of the company’s capacity expansion is done and it will become free-cash flow positive, after several years.
Despite an estimate-busting March quarter numbers and a positive management outlook for the current fiscal, the stock closed a measly 0.2% higher from its previous close.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon